Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxxx

xx xxx 20. xxxxxxxxx 2014

x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx a mimořádná xxxxxxxx xxx rok 2015

Xxxxxxxxxxxx zdravotnictví xxxxx §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x xxxxxxx veřejného xxxxxx x x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx imunizační xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx pro xxx 2015:

1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx

1x) xxxxxxxxxxx xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, nákazám xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (DTaPHibVHBIPV):

Pertussis xxxxxxxxxx

Xxxxxxxxx haemagglutinum xxxxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx

Xxxxxx xxxxxxxxxx xxx.

Xxxxxxxxx xxxxxxxxx hepatitidis X xxxxxxxxxxxxxx

Xxxxx poliomyelitidis xxxxxxxxxxx xxxxx 1

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3

Xxxxxxxxxx Hib: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx očkovací látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské přenosné xxxxx (xxxxxxxxxxxx forma), xxxxxx hepatitidě X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx typ b ( DTaPHibVHBIPV)

Diphtheriae xxxxxxxxxx

Xxxxxx xxxxxxxxxx

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxxxxxxx filamentosum

Virus Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)

xxxxx 1 (Mahoney)

typus 2 (XXX-1)

xxxxx 3 (Xxxxxxx)

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X

Xxxxxxxxxxx xxxxxxxxxx xxxx x polysaccharidum

(Polyribosylribitoli phasphas)

conjugata xxx tetani xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx anatoxinum ≥ 40 xxxxxxxxxxxxx jednotek

Pertussis xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum filamentosum (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):

Xxxxxxxxxxx xxxxxxxxxx ........................................... min. 30 mezinárodních xxxxxxxx

Xxxxxx xxxxxxxxxx .................................................... min. 40 xxxxxxxxxxxxx jednotek

Pertussis xxxxxxxxxx (XX) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) .... 25 mikrogramů

Pertactinum (69xX) ................................................... 8 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx X ....................................... 10 mikrogramů

cum xxxxxxxxx xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x:

1 dávka lyofilizované xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx xxxxx xxxxxx:

Xxxxxx xxxxxxxxxx ................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx B do 15 xxx xxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis X .......................... 10 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xx 16 xxx x xxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx B ........................... 20 xxxxxxxxxx

1x) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám:

Morbillorum xxxxx xxxxxxxxxx (Schwarz) xxx. 10^3,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx xxxxx attenuatum (XXX 4385) min. 10^3,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu₅₀

Rubeolae xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 10^3,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx₅₀

1xx) xxxxxxxx xxxxx xxxxx xxxxxx přenosné obrně x xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Xxxxxxx) ........... 40 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 2 (MEF-1) ................ 8 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx D xxxxxxxx*

* xxxx množství xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.

1x) xxxxxxxx xxxxx proti xxxxxxx vyvolaným Xxxxxxxxxxxxx xxxxxxxxxx v polysacharidové xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx pneumoniae xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11 X, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23X, 33X ...... 25 xxxxxxxxxx x xxxxxxx xxxxxxxx

1x) xxxxxxxx látka konjugovaná xxxxx xxxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 5

Pneumococcale xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 9V

Pneumococcale xxxxxxxxxxxxxxx sérotypus 14

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 18C

Pneumococcale xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X

1xx) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma):

Diphtheriae xxxxxxxxxx ............................... xx méně xxx 2 xxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx ........................................ xx méně xxx 20 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx................................... 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx ... 8 mikrogramů

Pertaktin ...................................................... 2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx inactivatum:

typus 1 (xxxx Mahoney) .............................. 40 X xxxxxxxx xxxxxxxx

xxxxx 2 (xxxx XXX-1) ................................... 8 X xxxxxxxx antigenu

typus 3 (kmen Saukett) ................................ 32 X xxxxxxxx xxxxxxxx

XXXX

1xx) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx ....................................... xxxx nebo xxxxx 2 xxxxxxxxxxx jednotky (2 Xx)

Xxxxxxxxx xxxxxx ....................................... xxxx xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxx ................................ 2,5 xxxxxxxxxx

Xxxxxxxxxxxx hemaglutinin ................. 5 xxxxxxxxxx

Xxxxxxx xxxx 2+3 ................................ 5 xxxxxxxxxx

Xxxxxxxxx ............................................. 3 mikrogramy

Virus xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) ... 40 xxxxxxxxxxx X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) ... 8 antigenních X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) ... 32 xxxxxxxxxxx X xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx:

Xxxxxxxxxxxxx xxxxx xxxxxxxxxx (BCG) xxxxxxx Xxxxxxx 1331 ... 0,75 xx&xxxx;≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X pro osoby xxxxxxxx do dialyzačního xxxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid A (XXX) 50 xxxxxxxxxx x 1 xxxxx

2. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx zvláštní xxxxxxxx

2x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X 20 xxxxxxxxxx

2x) xxxxxxxx xxxxx xxxxx vzteklině

Virus rabiei xxxxxxxxxxx (kmen Xxxxxx xxxxxx XX/XX 38 1503-3M xxxx xxxx xxxxx 2,5 xxxxxxxxxxxxx jednotek x 1 dávce (0,5 xx)

2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx X xxxxx xxxxxxxxxxx

3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxx

3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:

Xxxxxxxxx A xxxxx xxxxxxxxxxx

3x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx A xx xxxxxxx xxx děti:

Virus xxxxxxxxx X xxxxxxxxxxx

X xxxx 2015 x xxxxxxx na xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x očkování xxxxx xxxxxxxxx nemocem, xxxxx xxxxxxxx případnou úpravu xxxxxxxxxxx složení očkovacích xxxxx pro xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx nového xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx látek xx Xxxxxx xxxxxx.

Xxxxxxx:

XXXx. Xxxxxxx, XXX, x. x.

Xxxxxxxxx

Xxxxxx xxxxxxx x. 278/2014 Xx. xxxxx xxxxxxxxx xxxx 13.12.2014.

Ke xxx uzávěrky právní xxxxxxx xxxxx xxxxx xx doplňován.

Znění jednotlivých xxxxxxxx xxxxx jiných xxxxxxxx předpisů v xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx jich xxxxxx derogační změna xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.